Drug Type Monoclonal antibody |
Synonyms IGFBP2 monoclonal antibody (RGenix) |
Target |
Mechanism IGFBP2 modulators(IGF binding protein-2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Discovery | US | - |